Skip to content Skip to menu

Medicines Australia welcomes new AMA chief

Friday, 4 May 2018

Media Release

Medicines Australia (MA) congratulates the AMA on the appointment of Dr Michael Schaper as its next Secretary General.  Dr Schaper has extensive background and experience in business, government, and academia – most recently as Deputy Chairman of the Australian Competition and Consumer Commission (ACCC).

Interim CEO of MA, Mrs Elizabeth de Somer said, “Medicines Australia and the AMA have a long and constructive history of collaboration. I look forward to working with Dr Schaper to continue and strengthen this.”

“Dr Schaper’s knowledge of the machinations of Government, and of the business environment mean he is well placed to represent the needs of AMA members and lead the organisation through the next important stage in the political cycle,” Mrs de Somer said.

MA also recognises the outstanding contribution of Anne Trimmer who has led the AMA for the past 5 years.

“Ms Trimmer has been responsible for some remarkable achievements and has provided strong, stable leadership of the AMA.

Mrs de Somer also said, “Under Anne’s direction, the AMA has worked with Medicines Australia and the wider industry to set the agenda on many important issues such as reforms to the Medicare Rebate, the education of medical practitioners and private health care reform.”

“I wish Anne success in her future endeavours,” said Mrs de Somer.

 

-END-

CONTACT:

Natalie Wimmer
0450 728 660
nwimmer@medaus.com.au

Information

As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at medicinesaustralia.com.au/covid-19/

Top